🔎 Trials Near Me

Home › NCT06860425

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Diagnosis of invasive malignancy of the brain, head and neck region, lung, breast (DCIS and invasive disease allowed), prostate, gastrointestinal system or gynecological region
* Planned to receive, or have received, radiation therapy treatment with curative intent

  * Note: Patients undergoing systemic therapy are eligible
  * Note: Any dose/fractionation of curative-intent radiation therapy is eligible
* Patients must have a smartphone or other device with the ability to receive text messages, download and use mobile applications
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2
* Ability to read and write in English
* Provide written informed consent to participate in the study o NOTE: Patients enrolled on another clinical trial are eligible

Exclusion Criteria:

* Metastatic cancer
* Undergoing treatment with palliative intent
* Poorly controlled diabetes (defined as fasting glucose level \> 200 mg/dL despite attempts to improve glucose control by fasting duration and adjustment of medications)
* Uncontrolled hypertension
* Any medical condition requiring fluid restriction or nutrient restrictions

About the study

The overarching purpose of this study is to assess whether patients will use the app throughout treatment on a regular basis, as the ultimate goal is to provide an educational platform that can impact patient behaviors and understanding towards health.

What is being tested

Sponsor: Montefiore Medical Center · Participants: 50 · Started: Feb 28, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06860425

Locations in the U.S.

New YorkMontefiore Einstein Comprehensive Cancer Center, The Bronx

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.